Document Detail


The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.
MedLine Citation:
PMID:  19996335     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE: The response characteristics of the 6 minute walk test (6MWT) in studies of idiopathic pulmonary fibrosis (IPF) are only poorly understood, and the change in walk distance that constitutes the minimum important difference (MID) over time is unknown.
OBJECTIVES: To examine changes over time in distance walked (ie, 6MWD) during the 6MWT and to estimate the change in distance that constitutes the MID in patients with IPF.
METHODS: Data from a recently completed trial that included subjects with IPF who completed the 6MWT, Saint George's Respiratory Questionnaire (SGRQ) and forced vital capacity (FVC) at 6 and 12 months were used to examine longitudinal changes in 6MWD. Both anchor- and distribution-based approaches as well as linear regression analyses were used to determine the MID for 6MWD. The SGRQ Total score and FVC were used as clinical anchors.
MAIN RESULTS: Among 123 subjects alive and able to complete the 6MWT at both follow-up time points, 6MWD did not change significantly over time (378.1 m at baseline vs 376.8 m at 6 months vs 361.3 m at 12 months, p=0.5). The point estimate for the 6MWD MID was 28 m with a range of 10.8-58.5 m.
CONCLUSION: In a group of patients with IPF with moderate physiological impairment, for those alive and able to complete a 6MWT, 6MWD does not change over 12 months. At the population level, the MID for 6MWD appears to be approximately 28 m. Further investigation using other anchors and derivation methods is required to refine estimates of the MID for 6MWD in this patient population.
Authors:
Jeffrey J Swigris; Frederick S Wamboldt; Juergen Behr; Roland M du Bois; Talmadge E King; Ganesh Raghu; Kevin K Brown
Related Documents :
2951815 - Long-term treatment with 'duovent' in elderly patients affected by chronic obstructive ...
7677465 - Reduction pneumonoplasty for emphysema. early results.
20072975 - Role of inhaled tiotropium on the perioperative outcomes of patients with lung cancer a...
4004535 - Chest physical therapy: comparative efficacy of preoperative and postoperative in the e...
2380935 - Chronic postoperative endophthalmitis from staphylococcus aureus.
23587875 - I.v. and perineural dexamethasone are equivalent in increasing the analgesic duration o...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial     Date:  2009-12-08
Journal Detail:
Title:  Thorax     Volume:  65     ISSN:  1468-3296     ISO Abbreviation:  Thorax     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-11     Completed Date:  2010-03-08     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  England    
Other Details:
Languages:  eng     Pagination:  173-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antihypertensive Agents / therapeutic use
Double-Blind Method
Exercise Test* / methods
Female
Follow-Up Studies
Humans
Idiopathic Pulmonary Fibrosis / drug therapy,  physiopathology*
Male
Middle Aged
Prospective Studies
Sulfonamides / therapeutic use
Treatment Outcome
Vital Capacity / drug effects,  physiology
Walking / physiology*
Grant Support
ID/Acronym/Agency:
K23 HL092227/HL/NHLBI NIH HHS; K23 HL092227-01A2/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Sulfonamides; Q326023R30/bosentan
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interval versus continuous training in individuals with COPD - a systematic review.
Next Document:  Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12.